乙2抗逆转录酶激活剂 通过同情促进维持发热和瘦身
bioRxiv : the preprint server for biology
|July 16, 2025
概括
交感神经元中的β-2 adrenoceptor (β2AR) 调节热生成和体重. 准这种受体可能为治疗肥胖提供了一个新的策略.
科学领域:
- 神经内分泌学神经内分泌学
- 代谢调节 代谢调节 代谢调节
- 脂肪组织生物学 脂肪组织生物学
背景情况:
- 人类热生成依赖于脂肪细胞上的β-2上腺受体 (β2AR),由交感神经系统的诺尔上腺素激活.
- 在温度调节和脂肪性中,在交感神经元内β2AR的前突触作用仍然在很大程度上未被描述.
研究的目的:
- 为了研究β2AR在交感神经元中的前突触功能.
- 确定同情神经元中β2AR信号传递对发热和体重调节的影响.
主要方法:
- 在人类和动物宫交感神经元中识别Adrb2表达.
- 在小鼠中评估β2AR激素对交感神经元神经变性质和胆固醇反应效应的影响.
- 对小鼠交感神经元中选择性β2AR删除的表型后果的分析,包括神经活动,温度调节和身体组成.
主要成果:
- 在人类和动物的宫交感神经元中表达Adrb2.
- β2AR激活促进神经营养效应,并增强小鼠交感神经元中的胆固醇反应能力.
- 在交感神经元中选择性删除β2AR导致棕色脂肪组织交感神经活动受损,神经病变,加剧的禁食诱导的低温症和渐进的肥胖症,而不改变食物摄入量.
结论:
- 交感神经元β2AR在维持发热和调节脂肪性方面起着至关重要的前突触作用.
- 通过突触前β2AR的交感促进是肥胖症的潜在治疗标.
相关概念视频
Thermoregulation
1.3K
The human body has a sophisticated thermoregulation system that employs negative feedback mechanisms to maintain an optimal core temperature. When the core temperature drops, peripheral and central thermoreceptors send signals to the hypothalamus, activating the heat-promoting center. This center triggers several responses aimed at increasing the core temperature. First, vasoconstriction reduces the flow of warm blood from internal organs to the skin so that the heat is not lost from the skin,...
1.3K
Sympathetic Signaling
1.3K
Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
1.3K
Antiasthma Drugs: β2-Adrenoceptor Agonists
392
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
392
Adrenergic Agonists: Direct-Acting Agents
1.8K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.8K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.3K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.3K
Adrenergic Agonists: Indirect-Acting Agents
1.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.9K


